S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Applied Materials stock is Ray Dalio's favorite in this new cycle
Palo Alto Networks aims at cyber security leadership
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Spotify sounding better to analysts as company tunes into profits
3 Reasons the Capital One-Discover merger is a big deal
AI Stock Caught Trading Under Secret Name (Ad)
How major US stock indexes fared Wednesday, 2/21/2024
Bears covered shorts on this ETF, 3 stocks to pop on the shift
S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Applied Materials stock is Ray Dalio's favorite in this new cycle
Palo Alto Networks aims at cyber security leadership
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Spotify sounding better to analysts as company tunes into profits
3 Reasons the Capital One-Discover merger is a big deal
AI Stock Caught Trading Under Secret Name (Ad)
How major US stock indexes fared Wednesday, 2/21/2024
Bears covered shorts on this ETF, 3 stocks to pop on the shift
S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Applied Materials stock is Ray Dalio's favorite in this new cycle
Palo Alto Networks aims at cyber security leadership
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Spotify sounding better to analysts as company tunes into profits
3 Reasons the Capital One-Discover merger is a big deal
AI Stock Caught Trading Under Secret Name (Ad)
How major US stock indexes fared Wednesday, 2/21/2024
Bears covered shorts on this ETF, 3 stocks to pop on the shift
S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Applied Materials stock is Ray Dalio's favorite in this new cycle
Palo Alto Networks aims at cyber security leadership
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Spotify sounding better to analysts as company tunes into profits
3 Reasons the Capital One-Discover merger is a big deal
AI Stock Caught Trading Under Secret Name (Ad)
How major US stock indexes fared Wednesday, 2/21/2024
Bears covered shorts on this ETF, 3 stocks to pop on the shift

Cardiol Therapeutics (CRDL) News Today

C$1.99
-0.26 (-11.56%)
(As of 02/21/2024 ET)
SourceHeadline
finance.yahoo.com logoCardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis
finance.yahoo.com - February 21 at 8:53 AM
MarketBeat logoCardiol Therapeutics (TSE:CRDL) Shares Down 10.1%
americanbankingnews.com - February 18 at 2:16 AM
MarketBeat logoCardiol Therapeutics (TSE:CRDL) Stock Price Up 18.3%
americanbankingnews.com - February 17 at 6:46 AM
theglobeandmail.com logoClosing Bell: Cardiol Therapeutics Inc Purchase WT down on Monday (CRDL-WT-A)
theglobeandmail.com - February 9 at 8:03 AM
finance.yahoo.com logoIs Cardiol Therapeutics (TSE:CRDL) In A Good Position To Invest In Growth?
finance.yahoo.com - February 2 at 12:14 PM
morningstar.com logoCardiol Therapeutics Inc Class A
morningstar.com - January 30 at 8:57 AM
finance.yahoo.com logoCardiol Therapeutics Announces Massachusetts General Hospital, Largest Teaching Hospital of Harvard Medical School, as the 8th Major Medical Centre Participating in MAvERIC-Pilot
finance.yahoo.com - December 5 at 9:44 AM
proactiveinvestors.com logoCardiol Therapeutics reaches new milestone in Phase II study for recurrent pericarditis
proactiveinvestors.com - November 1 at 9:27 AM
finance.yahoo.com logoCardiol Therapeutics Announces It Has Exceeded 50% Enrollment in Its Phase II MAvERIC-Pilot Study in Recurrent Pericarditis
finance.yahoo.com - November 1 at 9:27 AM
finanznachrichten.de logoCardiol Therapeutics Inc.: Cardiol Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
finanznachrichten.de - October 23 at 1:08 PM
finance.yahoo.com logoCardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases
finance.yahoo.com - October 13 at 12:51 PM
finance.yahoo.com logoCardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases
finance.yahoo.com - October 13 at 12:51 PM
proactiveinvestors.com logoCardiol Therapeutics releases positive study results of...Cardiol Therapeutics releases positive study results of...
proactiveinvestors.com - October 11 at 1:00 PM
benzinga.com logoCBD To Treat Heart Failure? New Study Shows Its Cardioprotective Effects
benzinga.com - October 10 at 3:47 PM
finanznachrichten.de logoCardiol Therapeutics Inc.: Cardiol Therapeutics to Present at Cantor Fitzgerald 2023 Global Healthcare Conference
finanznachrichten.de - September 28 at 1:00 PM
finance.yahoo.com logoCardiol Therapeutics to Present at Cantor Fitzgerald 2023 Global Healthcare Conference
finance.yahoo.com - September 26 at 8:30 AM
proactiveinvestors.com logoCardiol Therapeutics on track to complete enrollment for acute myocarditis trial six months ahead of schedule
proactiveinvestors.com - September 19 at 12:04 PM
msn.com logoCardiol Therapeutics Inc. (CRDL) Upgraded to Buy: Here's What You Should Know
msn.com - August 16 at 1:30 PM
finance.yahoo.com logoCRDL.TO - Cardiol Therapeutics Inc.
finance.yahoo.com - June 6 at 3:08 PM
investing.com logoCardiol Therapeutics (CRDL) Earnings Dates & Reports
investing.com - May 19 at 9:03 AM
theglobeandmail.com logoClosing Bell: Cardiol Therapeutics Inc down on Monday (CRDL)
theglobeandmail.com - May 9 at 12:58 AM
theglobeandmail.com logoClosing Bell: Cardiol Therapeutics Inc up on Friday (CRDL)
theglobeandmail.com - April 21 at 7:49 PM
theglobeandmail.com logoClosing Bell: Cardiol Therapeutics Inc up on Tuesday (CRDL)
theglobeandmail.com - April 12 at 1:30 AM
theglobeandmail.com logoClosing Bell: Cardiol Therapeutics Inc flat on Thursday (CRDL)
theglobeandmail.com - April 8 at 6:07 AM
theglobeandmail.com logoClosing Bell: Cardiol Therapeutics Inc down on Wednesday (CRDL)
theglobeandmail.com - April 6 at 4:25 PM
uk.finance.yahoo.com logoCardiol Therapeutics Inc. (CRDL.TO)
uk.finance.yahoo.com - April 1 at 11:50 PM
finance.yahoo.com logoCardiol Therapeutics Announces Study Results from Collaborating Research Center Demonstrating Cardioprotective Effects of Cannabidiol in a Model of Heart Failure
finance.yahoo.com - March 7 at 8:35 AM
seekingalpha.com logoCRDL Cardiol Therapeutics Inc.
seekingalpha.com - February 17 at 8:00 AM
proactiveinvestors.com logoCardiol Therapeutics enrols first patient in Phase 2 study of CardiolRx for Recurrent Pericarditis
proactiveinvestors.com - January 17 at 5:30 PM
finanznachrichten.de logoCardiol Therapeutics Inc.: Cardiol Therapeutics Commences Multi-Center Phase II Pilot Study of CardiolRx for the Treatment of Recurrent Pericarditis
finanznachrichten.de - December 12 at 8:25 AM
finance.yahoo.com logoCardiol Therapeutics Commences Multi-Center Phase II Pilot Study of CardiolRx(TM) for the Treatment of Recurrent Pericarditis
finance.yahoo.com - December 12 at 8:25 AM
finance.yahoo.com logoCardiol Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
finance.yahoo.com - November 15 at 2:11 AM
finance.yahoo.com logoCardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx(TM) in a Model of Acute Pericarditis
finance.yahoo.com - November 7 at 8:23 AM
proactiveinvestors.com logoCardiol Therapeutics to prioritize its Phase II clinical programs focused on developing CardiolRx for two underserved diseases affecting the heart
proactiveinvestors.com - October 25 at 11:48 AM
finance.yahoo.com logoCardiol Therapeutics Prioritizes Phase II Clinical Programs in Underserved Heart Diseases
finance.yahoo.com - October 25 at 6:47 AM
proactiveinvestors.com logoCardiol Therapeutics unveils new preclinical study results providing evidence of cardioprotective properties of CardiolRx
proactiveinvestors.com - October 3 at 1:33 PM
finance.yahoo.com logoCardiol Therapeutics Announces Pre-Clinical Study Results Demonstrating CardiolRx(TM) Inhibits and also Promotes Reversal of Mechanisms Leading to Cardiac Fibrosis
finance.yahoo.com - October 3 at 8:32 AM
finance.yahoo.com logoCardiol Therapeutics Announces Poster Presentation at The Annual Scientific Meeting of the Heart Failure Society of America
finance.yahoo.com - September 28 at 9:49 AM
proactiveinvestors.com logoCardiol Therapeutics says first patient enrolled in acute myocarditis trial of its oral cannabinoid formulation CardiolRx
proactiveinvestors.com - August 3 at 3:01 PM
proactiveinvestors.com logoCardiol Therapeutics hits major milestone with first patient enrolled in Phase 2 trial of CardiolRX
proactiveinvestors.com - August 3 at 3:01 PM
finanznachrichten.de logoFinancialnewsmedia.com: Air Pollution is a Global Heart and Lung Health Concern
finanznachrichten.de - July 18 at 1:48 PM
finance.yahoo.com logoCardiol Therapeutics Reports Results of 2022 Annual General Meeting
finance.yahoo.com - June 29 at 6:04 PM
finance.yahoo.com logoCardiol Therapeutics to Webcast Virtual Annual General Meeting on June 28th at 4:30 P.M. EDT
finance.yahoo.com - June 27 at 5:46 PM
proactiveinvestors.com logoCardiol Therapeutics is conducting clinical trials of its pure cannabidiol formulation, CardiolRx, to treat inflammatory heart disease
proactiveinvestors.com - June 16 at 12:38 PM
finanznachrichten.de logoFinancialnewsmedia.com: Breakthroughs In Treating Killer Diseases Could Lengthen Life
finanznachrichten.de - June 7 at 11:53 AM
benzinga.com logoBreakthroughs In Treating Killer Diseases Could Lengthen Life
benzinga.com - June 7 at 11:53 AM
finance.yahoo.com logoMarket Movers. Today’s Top Stock Picks For New & Trending Opportunities
finance.yahoo.com - May 27 at 2:32 PM
seekingalpha.com logoCardiol wins FDA nod to study oral cannabidiol drug in recurrent pericarditis
seekingalpha.com - May 17 at 8:35 AM
finanznachrichten.de logoFinancialNewsMedia.com: Heart Failure Treatment Offers Hope to Diabetics
finanznachrichten.de - May 11 at 9:35 AM
investing.com logoInterview: Cardiol Therapeutics' CEO on the Company's Market Debut and Future
investing.com - March 30 at 12:04 PM
Get Cardiol Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter.



CRDL Media Mentions By Week

CRDL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CRDL
News Sentiment

0.34

0.52

Average
Medical
News Sentiment

CRDL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CRDL Articles
This Week

3

0

CRDL Articles
Average Week

Get Cardiol Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (TSE:CRDL) was last updated on 2/22/2024 by MarketBeat.com Staff